[Update on the pharmacotherapy of chronic heart failure with reduced ejection fraction: from four to six pillars?]
{{output}}
Contemporary pharmacotherapy of chronic heart failure with reduced ejection fraction (HFrEF) consists of angiotensin receptor-neprilysin inhibitors, beta blockers, mineralocorticoid receptor antagonists and sodium glucose cotransporter 2 inhibitors. In this ye... ...
